Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference

February 25, 2026 - 17:14

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, has announced its participation in the upcoming 46th Annual TD Cowen Health Care Conference. The company's presentation is scheduled for Monday, March 2, 2026.

The conference is a key forum where leading healthcare companies connect with the investment community. Anavex's management is expected to provide a comprehensive overview of the company's development pipeline, which focuses on novel therapies for neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, and Rett syndrome.

Investors and interested parties will have the opportunity to access a live audio webcast of the corporate presentation. This event allows for direct communication from company leadership regarding recent progress, clinical milestones, and the strategic direction of its research programs. The presentation will be closely watched by analysts and shareholders for updates on the company's lead drug candidate, blarcamesine, and its potential across multiple central nervous system conditions.